Best Chemotherapy for esophageal carcinoma Doctors Worldwide — TOP 51

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a leader in sarcoma treatment with decades of specialized experience.

• Over 41 years of experience focused on sarcoma and thoracic oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• ESMO faculty member for sarcoma treatment protocols
• Published extensively on orthopedic oncology outcomes
• Former Chairman of Israel's Oncology and Radiotherapy Society

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Prof. Arber specializes in GI cancer prevention and treatment, with over 44 years of experience of experience, including leading the Cancer Prevention Center at Sourasky Medical Center.

• Heads the Integrated Cancer Prevention Center at Sourasky Medical Center
• Published over 300 papers on GI cancer research and treatment
• Fellowship trained in gastroenterology at NewYork-Presbyterian Center
• Member of multiple international cancer and gastroenterology associations
• Specializes in early detection and prevention of GI tumors

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Prof. Sezer Sağlam specializes in gastrointestinal oncology with over 27 years of experience of focused experience. He leads the Medical Oncology Department at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Expert in neuroendocrine tumors (ENET member)

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Osama Abdel Mohimen Mohamed leads the Hematology Unit at Shefaa Al Orman Oncology Hospital. He treats complex blood cancers, including leukemia, lymphoma, and myeloma. Dr. Mohamed is a member of the European Society for Medical Oncology. He also holds memberships in the American Society of Hematology and ASBMT.

• Specializes in chemotherapy, immunotherapy, and bone marrow transplantation.
• Manages aggressive acute leukemia and chronic blood disorders.
• Treats complications arising from various solid tumors.
• Works at an ESMO-accredited center that handles 6,000 patients annually.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Solak specializes in gastrointestinal cancers, including esophageal carcinoma, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Trained at The University of Texas MD Anderson Cancer Center
• Experienced in treating various cancers, including gastrointestinal types
• Works at Hisar Hospital Intercontinental

Dr. Yesim Yildirim is a medical oncologist at Anadolu Medical Center. She specializes in immunotherapy and targeted therapy for breast, lung, and gastrointestinal cancers. Dr. Yildirim is ESMO-certified and holds the rank of Professor. She completed training at Mount Vernon in the UK and Rambam Medical Center.

• Authored over 80 scientific publications on tumor biology and precision medicine.
• Treats complex cases including melanoma, sarcomas, and stage 4 lung cancer.
• Member of ASCO and the International Society of Gastrointestinal Oncology.
• Works at Anadolu Medical Center, an affiliate of Johns Hopkins Hospital.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Wolf leads the Medical Oncology Division at Sourasky Medical Center – one of Israel's leading hospitals.

• Specializes in oncology and internal medicine
• Trained at Ben Gurion University of the Negev
• Extensive experience across various medical units

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr. Dror Levin specializes in pediatric hematology oncology, with a focus on bone cancer (sarcoma) in children at Sourasky Medical Center.

• Director of children's hematology oncology department at Sourasky
• Coordinates treatment of bone cancer and soft tissue sarcoma in children
• Member of ISPHO – Israel's pediatric hemato-oncology association
• Trained at Rizzoli Orthopaedic Institute in Bologna – a leading sarcoma center

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads a specialized team for esophageal carcinoma treatment.

• Over 26 years of experience of oncology experience
• Primary researcher in multiple clinical trials for new chemotherapy protocols
• Trained at Tel Aviv Medical Center, Israel's leading oncology hospital
• Specializes in internal medicine and oncology

Professor Saglam specializes in gastrointestinal oncology at Florence Nightingale Hospital, with over 29 years of experience of focused expertise in medical oncology.

• Board-certified in medical oncology since 2004
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
• Completed fellowship at Istanbul University Oncology Institute
• Practices at Istanbul Florence Nightingale Hospital

Phd Viola Fox leads the Clinic for Haematology, Oncology and Palliative Care at BKZ Solingen – a certified interdisciplinary cancer center.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with molecular diagnostics expertise
• Active researcher in molecular biology for haemato-oncological diseases
• Member of German and American oncology societies